* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Sichuan Kelun Pharmaceutical Co Gross Profit Chart
Competitive Comparison of Sichuan Kelun Pharmaceutical Co's Gross Profit
For the Drug Manufacturers - General subindustry, Sichuan Kelun Pharmaceutical Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sichuan Kelun Pharmaceutical Co's Gross Profit Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sichuan Kelun Pharmaceutical Co's Gross Profit distribution charts can be found below:
* The bar in red indicates where Sichuan Kelun Pharmaceutical Co's Gross Profit falls into.
Sichuan Kelun Pharmaceutical Co Gross Profit Calculation
Gross Profit is the different between the sale prices and the cost of buying or producing the goods.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥11,634 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sichuan Kelun Pharmaceutical Co (SZSE:002422) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sichuan Kelun Pharmaceutical Co had a gross margin of 55.84% for the quarter that ended in Mar. 2024 => Durable competitive advantage
Sichuan Kelun Pharmaceutical Co Gross Profit Related Terms
Thank you for viewing the detailed overview of Sichuan Kelun Pharmaceutical Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Sichuan Kelun Pharmaceutical Co (SZSE:002422) Business Description
Sichuan Kelun Pharmaceutical Co Ltd is a China-based Pharmaceutical company mainly focused on the production and sales of injection products, including products for glucose injection and sodium chloride injection. It manufactures and sells high-volume injections (infusions), small-volume injections (water needles), sterile powder injections (containing powdered and freeze-dried powder). Its products include tablets, capsules, capsules, granules, oral liquids, peritoneal dialysis fluids, raw material medicines, medical packaging materials, medical instruments, and antibiotic intermediates.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:002422 has been successfully added to your 